ZSTK Flora Growth Corp. Insider Trading

Executive Chairman Michael Heinrich buys 4,608,575 shares at $0.75, acquiring $3.5M stake amid -76.4% 90-day decline and -40.0% annual revenue contraction.

Michael Heinrich, as Executive Chairman, purchased 4,608,575 shares at $0.75 on 2026-07-20 for a total value of $3,479,013.27, acquiring his first significant stake in ZeroStack Corp. The timing is notable given the company's financial deterioration: annual revenue has declined -40.0%, the company reported a net loss of $-36,660,000.00 in its most recent full fiscal year, and the stock has fallen -76.4% over the past 90 days from a 52-week high of $15.04. At the current price of $1.65, the stock trades -89.0% below its 52-week high. With market cap of just $4,010,277.15 and the latest quarterly revenue at $7,274,000.00, the company faces severe operating and financial distress. The executive's entry at $0.75 during this downturn, combined with his retention of 500,000 employee stock options, warrants scrutiny as to whether this reflects conviction in a turnaround thesis or represents a distressed situation requiring capital injection from leadership.

CEO Starke Clifford buys 6,795 shares of FLGC at $0.95; holdings surge +13323.5% to 6,846 shares

Starke Clifford, CEO of Flora Growth Corp., purchased 6,795 shares at $0.95 on 2024-09-13, increasing his holdings from 51 shares to 6,846 shares—a +13323.5% increase in position size. This transaction follows a prior buy at the same ticker on 2024-09-05 and represents a consecutive accumulation pattern within nine days. Across his open-market history, his cross-ticker track record shows 2 prior buys with an avg 90d return of +1788.4% and a 100.00% 90d win rate; at FLGC specifically, his 2024-04-08 buy generated a 90d return of +1788.4%, indicating prior success timing buys at this ticker. The current stock price of $45.24 is -60.0% from the 52-week high of $113.10, yet trading +26.0% over the past 30 days and +13.7% over 90 days, suggesting recent momentum despite year-to-date weakness. The company remains unprofitable (latest quarter net income of $-2,630,000.00) and full-year net income was negative, though annual revenue growth of +104.6% indicates substantial business expansion; market cap stands at $604,702,043.40. The rapid, consecutive accumulation by the CEO at depressed valuations combined with his demonstrated execution track record warrants investor attention to Flora Growth's near-term trajectory.

Director Wolkin buys 25,000 shares at $0.97 avg; stock down 74.3% from 52-week high of $142.74

Wolkin Harold, a Director at Flora Growth Corp., executed 3 separate purchases totaling 25,000 shares for $24,255.00 at an average price of $0.97 on 2024-09-06, establishing an initial position after holding zero shares. The purchase occurs while the stock trades at $36.66, down 74.3% from its 52-week high of $142.74, suggesting a significant pullback from recent valuation peaks. The company generated $15.7M in quarterly revenue with 104.6% annual growth but remains unprofitable with a $-2.6M net income in the most recent full fiscal year. The transaction represents a material accumulation at substantially depressed levels relative to recent trading history, though the substantial distance from the 52-week high and ongoing losses warrant assessment of whether this reflects opportunistic entry or other considerations beyond valuation context.

CEO Starke Clifford bought 51 shares of FLGC at $0.95 on 2024-09-05; stock now $38.85, -73.9% from 52-week high.

Starke Clifford purchased 51 shares worth $48.45, representing a minimal addition to his 474,046-share position at a significant discount to current price. His prior buy at this ticker on 2024-04-08 showed strong subsequent returns (+3020.0% over 30 days, +1788.4% over 90 days), but that exceptional performance does not contextualize the current transaction—the stock is now -73.9% from its 52-week high, suggesting a different market environment. The company generated $15,683,000 in latest-quarter revenue with an annual growth rate of +104.6%, yet remains unprofitable with $-2,630,000 net income; this combination (high growth, ongoing losses) reflects a growth-stage profile vulnerable to valuation compression. The minimal transaction size and unremarkable position change (+0.0% of holdings) provide limited directional signal on executive conviction.